Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 101.20%372 | 74.45%-53.68K | 106.80%15K | -3.11%-624.55K | -46.36%-162.85K | 78.26%-30.97K | 12.00%-210.05K | -94.72%-220.68K | 2.90%-605.74K | 50.55%-111.26K |
| Net income from continuing operations | 45.45%-55.63K | 66.65%-62.56K | 78.77%-45.71K | -19.03%-705.58K | -8.77%-200.76K | 17.40%-101.99K | 5.80%-187.58K | -151.54%-215.25K | 38.11%-592.76K | 34.98%-184.57K |
| Remuneration paid in stock | --0 | --0 | --45.35K | ---- | ---- | --0 | --0 | --0 | --0 | ---- |
| Other non cashItems | ---- | ---- | ---- | -92.74%-57.51K | 0.78%-48.88K | 72.74%-1.48K | -73.50%7.78K | -232.55%-14.93K | 21.40%-29.84K | -215.35%-49.26K |
| Change In working capital | -22.75%56.01K | 129.37%8.88K | 61.72%15.36K | 721.82%138.54K | -29.19%86.79K | 635.41%72.5K | 56.10%-30.24K | 140.82%9.5K | -79.16%16.86K | 659.29%122.57K |
| -Change in receivables | -71.77%3.84K | -327.24%-17.78K | 748.49%37.46K | -108.34%-3.14K | -139.94%-18.8K | 128.76%13.61K | -84.18%7.82K | 50.15%-5.78K | 166.35%37.6K | 308.23%47.06K |
| -Change in prepaid assets | --0 | --0 | -211.11%-25K | 185.00%42.5K | -33.33%20K | 0.00%30K | 72.73%-30K | --22.5K | -144.25%-50K | 6.20%30K |
| -Change in payables and accrued expense | 80.58%52.16K | 430.49%26.66K | 140.15%2.9K | 239.02%99.18K | 88.09%85.59K | 660.78%28.89K | 3.54%-8.07K | 38.14%-7.23K | 19.08%29.26K | 333.57%45.5K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 101.20%372 | 74.45%-53.68K | 106.80%15K | -3.11%-624.55K | -46.36%-162.85K | 78.26%-30.97K | 12.00%-210.05K | -94.72%-220.68K | 2.90%-605.74K | 50.55%-111.26K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -90.21%22K | 1,651.73%26.28K | -47.25%357.33K | 131.05K | 0 | -65.60%224.78K | 0.00%1.5K | 1,206.00%677.37K | 0 |
| Net common stock issuance | --0 | -88.80%25K | --23.28K | -47.69%354.33K | --131.05K | --0 | --223.28K | --0 | 1,238.63%677.37K | --0 |
| Net other financing activities | ---- | ---- | 100.00%3K | --3K | --0 | --0 | --1.5K | 0.00%1.5K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | -90.21%22K | 1,651.73%26.28K | -47.25%357.33K | --131.05K | --0 | -65.60%224.78K | 0.00%1.5K | 1,206.00%677.37K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -59.51%36.17K | -9.07%67.84K | -90.96%26.57K | 32.25%293.79K | -85.59%58.36K | -82.98%89.33K | -32.37%74.61K | 32.25%293.79K | -72.03%222.15K | 2.53%405.05K |
| Current changes in cash | 101.20%372 | -315.12%-31.68K | 118.83%41.28K | -473.02%-267.22K | 71.42%-31.8K | 74.18%-30.97K | -96.45%14.73K | -95.99%-219.18K | 112.52%71.64K | 35.66%-111.26K |
| End cash Position | -37.39%36.54K | -59.51%36.17K | -9.07%67.84K | -90.96%26.57K | -90.96%26.57K | -85.59%58.36K | -82.98%89.33K | -32.37%74.61K | 32.25%293.79K | 32.25%293.79K |
| Free cash from | 101.20%372 | 74.45%-53.68K | 106.80%15K | -3.11%-624.55K | -46.36%-162.85K | 78.26%-30.97K | 12.00%-210.05K | -94.72%-220.68K | 2.90%-605.74K | 50.55%-111.26K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.